Abstract Diamond-Blackfan anemia is a bone marrow failure syndrome associated with heterozygous mutations in the ribosomal protein S19 (RPS19) gene in a subgroup of patients. One of the interacting partners with RPS19 is the oncoprotein PIM-1 kinase. We intercrossed Rps19 +/− and Pim-1 −/− mice strains to study the effect from the disruption of both genes. The double mutant (Rps19
Introduction
Diamond-Blackfan anemia (DBA) is a rare bone marrow failure sydrome characterized by an absence or decrease of erythroid precursor cells in the bone marrow but otherwise normal cellularity [1, 2] . In DBA, as in several bone marrow failure syndromes, affected individuals have an increased risk for developing malignant disease, specifically myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) [1, 3, 4] . Approximately 25% of patients with DBA are heterozygous for mutations in the ribosomal protein S19 gene (RPS19) [5] and another 10-20% of patients carry mutations in different ribosomal protein genes [6] . RPS19 deficiency in hematopoietic cells is associated with reduced erythroid proliferative capacity [7] , mitotic arrest in the G 0 /G 1 phase [8] and increased apoptosis of erythroid progenitors [9] . Impaired ribosomal biogenesis is a distinct feature in the pathophysiology of DBA but the connection to erythroid hypoplasia and the predisposition to myeloproliferative disease is unclear [10, 11] . It is assumed that the progression to MDS and leukemia requires additional mutations to reach clonal dominance [12] . Several factors interact with RPS19 [13] , one of which is identified as the serine-threonine kinase PIM-1 [14] . PIM-1 is ubiquitously present and highly expressed in hematopoietic tissues [15] where it promotes cell cycle progression, cell proliferation, and survival [16, 17] . The PIM-1-deficient mouse is characterized by microcytotic anemia and impaired erythroid colony forming capacity in vitro [18, 19] . PIM-1 is also recognized as a synergistic partner with c-Myc in tumorigenesis [20] and the transcriptional activity of c-Myc is dependent on histone phosphorylation by PIM-1 [21] . Moreover, PIM-1 phosphorylates the Cdc25A cell cycle phosphatase, which is a transcriptional target of c-Myc. This links PIM-1-mediated mitogenic signals to the cell cycle machinery [22] . The proto-oncogene c-Myc has a pivotal role in growth control, differentiation, and apoptosis. c-Myc can directly promote ribosome biogenesis and protein synthesis rate through transcription of several components in the translational machinery [23] . This seems to be counteracted by the ribosomal protein L11 which suppresses c-Myc activity [24] .
We have previously generated a mouse model with targeted disruption of Rps19 [25] . The Rps19 null mouse is lethal prior to implantation whereas the Rps19 heterozygous mice show a normal phenotype [26] . To clarify the significance of the previously reported RPS19 and PIM-1 interaction we generated mice with targeted disruptions of Rps19 and/or Pim-1. We present herein the results from the morphological and molecular analysis of hematopoietic organs in these mice strains. Our findings support a combined effect of Rps19 and Pim-1 mutations on myeloid proliferation and apoptosis.
Materials and methods

Generation of mice carrying Rps19 and Pim-1 disruptions
Rps19
+/− mice [25] were bred with 
Statistical analysis
Results are presented as means ± standard deviation.
Western blot experiments were conducted on pooled material. Quantitative real-time PCR experiments were set up in triplicates. Each experiment was repeated at least twice. Cell cycle experiments were repeated four times.
Results were tested for statistical significance using the two-tailed unpaired Student t test. p<0.05 was considered statistically significant [27] .
Results
Mice with a combined Rps19 and Pim-1 disruption have an increased myeloid/erythroid cellularity
To investigate the functional effect of Rps19 and Pim-1 we generated different combinations of Rps19 and Pim-1 genotypes by interbreeding the mice strains Rps19 Pim-1 −/− (n=23). The growth and weight was measured at age 6 weeks, with no significant differences between the four groups. None of the four groups showed any macroscopic abnormalities and the groups showed a similar survival rate up to the age of analysis (6-8 weeks). We were not able to show a reduction of Rps19 transcript levels in the Rps19 +/− Pim-1 +/+ and Rps19 +/− Pim-1 −/− mice as previously described [25] (data not shown). Pim-1 transcript levels were fully knocked down in the Rps19 ). The Hb levels were subnormal in the double mutant Rps19 +/− Pim-1 −/− mice but significantly increased when compared to the Pim-1-deficient mice (Table 1) . Similarly, the hematocrit was subnormal in the double mutant mice but significantly increased when compared to the single Pim-1 mutant mice. MCHC showed a tendency towards lower levels in the double mutant mice compared to the Pim-1 null mutant mice and the wild type but the variations are large within groups and no significant differences were detected.
Combined Rps19 and Pim-1 mutations do not affect bone marrow and spleen morphology
To investigate whether the observed altered RBC and WBC counts are reflected in morphological changes in the blood- Table S1 ). Furthermore, the histopathological analysis of spleens sections shows similar distribution of red and white pulp when comparing the four groups. This indicates that no increased red blood cell production or destruction is occurring in the spleen (Supplementary Fig. S1 ). (Fig. 1a, b) . When analyzing the levels of p53 we do not detect any differences between the four different groups (Fig. 1c) . Pim-1 +/+ mice, respectively ( Fig. 2a and b) . Similarly, we find a significant up-regulation in Bcl XL (p<0.05) in the double mutant (Rps19 +/− Pim-1
) mice when comparing to Rps19 +/+ Pim-1 +/+ mice (Fig. 2c) . We also detect a significant down-regulation of the apoptotic marker Bak (p<0.001) when comparing the double mutant (Rps19 +/− Pim-1 −/− ) mice to the other three groups, after normalization to beta-actin (Fig. 2d) . Similarly, we find a significant down-regulation of cleaved Caspase 3 (p<0.05) in the double mutant (Rps19 +/− Pim-1 −/− ) mice when comparing to Rps19 +/+ Pim-1 +/+ and Rps19 +/+ Pim-1 −/− mice, respectively (Fig. 2e) .
Discussion
To investigate the function of the RPS19 and PIM-1 interaction we generated different combinations of Rps19 and Pim-1 genotypes by interbreeding the Rps19 +/− and Pim-1 −/− mice strains [19, 25] . None of the four selected ) showed any detectable morphological or histopathological abnormalities in the BM or spleen. Next, we investigated peripheral blood from mice with the four different genotypes at 6-8 weeks of age for the standard parameters Hb, RBC, EVF, MCV, MCHC, and WBC ( Table 1 mice. In combination, these findings suggest that the interaction between RPS19 and PIM-1 [14] has an effect on proliferation and/or survival of both RBC and WBC. The increased myeloid cellularity in Rps19 +/− Pim-1
mice is associated with an up-regulation of c-Myc. Neither Pim-1 deficiency nor Rps19 haploinsufficiency alone did result in deregulation of c-Myc. It has been shown that cMyc cooperates with Pim-1; Pim-1 phosphorylates histones required for c-Myc-dependent transcription [21] and Pim-1 phosphorylates c-Myc itself [20] . In addition, c-Myc has been shown to directly promote ribosome biogenesis through the transcriptional regulation of ribosomal proteins, RNA polymerase I and III and factors involved in ribosome assembly [29, 30] . On the other hand, c-Myc activity is suppressed by ribosomal protein L11 [31] and by ribosomal protein L24 haploinsufficiency [32] . These results indicate a crosstalk between the c-Myc induced cell growth and the translational machinery. Thus, the increased levels of cMyc observed in Rps19 +/− Pim-1 −/− mice may be related to a loss of a feedback mechanism involving both Rps19 and Pim-1. c-Myc is essential for hematopoietic stem-cell renewal and cell cycle progression [33] . In addition, c-Myc sensitizes cells to apoptosis through the mitochondrial apoptosis pathway. c-Myc primes a molecular switch of the Bcl-2 family of proteins resulting in an activation of the apoptotic factors Bak-Bax whereas the antagonistic factors [34] . Overexpression of Bcl-2 has in early experiments been shown to block c-Myc-induced apoptosis without inhibiting cell cycle progression [35, 36] results, we suggest an inter-dependent effect of Rps19 and Pim-1 as sensitizers in murine myeloid cell growth. We hypothesize that the combination of Rps19 insufficiency and Pim-1 deficiency result in the loss of a regulatory loop involving c-Myc (Fig. 3) . According to this model, the crosstalk between Rps19 and c-Myc is modulated by Pim-1. The tuning of this crosstalk may be dependent on the expression of both Pim-1 and Rps19 with a variable impact on different lineages. In addition, the modulating effect may be further fine-tuned by the functional overlap between Pim-1, Pim-2, and Pim-3. It may be hypothesized that the Rps19 and Pim-1 interaction becomes critical during certain stages of myeloid/early erythroid differentiation with high demands on ribosomal functions and with insufficient compensatory mechanisms on Rps19 levels in heterozygous mice. In DBA, presumably associated with a normal PIM-1 expression, the relatively mild effects on myelopoiesis may be explained by lineage-specific effects of RPS19 insufficiency and a less efficient compensatory mechanism for RPS19 insufficiency when demands on the translational machinery are high.
In conclusion, our combined data show that allelic Rps19 insufficiency and Pim-1 deficiency have a cooperative effect on murine hematopoiesis resulting in an increased peripheral erythroid and myeloid cellularity. This is associated with deregulated c-Myc levels, expression of anti-apoptotic markers, and suppression of p21. RPS19 insufficiency in DBA is associated with increased disposition for MDS and AML which presumably requires a combination of mutations. We suggest that candidate target genes in this progression encode cell cycle regulators or anti-apoptotic factors with functions analogous to those of PIM-1.
